tag:blogger.com,1999:blog-35459715601901277852024-03-13T05:49:53.258-07:00Neurotech Club Online ForumNeurotech@MIT group blogAnonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.comBlogger12125tag:blogger.com,1999:blog-3545971560190127785.post-4216623735565297642009-02-24T19:53:00.000-08:002009-02-24T19:53:00.306-08:00Kauffman Foundation Study Finds MIT Alumni Companies Generate Billions for Regional Economies - MSNBC Wire Services - msnbc.com<a href="http://www.msnbc.msn.com/id/29238757/">Kauffman Foundation Study Finds MIT Alumni Companies Generate Billions for Regional Economies - MSNBC Wire Services - msnbc.com</a>Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-10179603826904199752009-01-30T05:25:00.000-08:002009-01-30T05:25:21.922-08:00Burgeoning field of neurotech spawns brainy businesses<a href="http://web.mit.edu/newsoffice/2009/neurotechnology-0129.html">Burgeoning field of neurotech spawns brainy businesses<br /> - MIT News Office</a><br /><br /><a href=""></a><br /><blockquote><br /></blockquote>Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-42514837206436715912008-12-10T13:59:00.000-08:002008-12-10T13:59:19.443-08:00Maximizing Progress: MIT Neurotechnology Ventures 2008 ~ Top Plans!<a href="http://www.maximizingprogress.org/2008/12/mit-neurotechnology-ventures-2008-great.html">Maximizing Progress: MIT Neurotechnology Ventures 2008 ~ Top Plans!</a><br /><br /><a href=""></a><br /><blockquote>Neurotech is a theme which embraces a broad array of issues and opportunities including: Neuroimaging, Neurology/Psychiatry Diagnosis, Rehabilitation, Neurosurgery, Neuropharmacology, Brain Stimulation, Prosthetics, Sensory and Motor Augmentation, Gaming, Learning, Neuroveterinary Solutions, Regenerative Neuromedicine, and more. I'm quite delighted by and proud of the teams which pulled together some bold and even excellent new venture proposals, including...<br /><br /> * Aivot ~ ePatch Cognitive Behavior Therapy to Quit Smoking<br /> * NeuroExtend ~ Veterinary Longevity Neural Implant<br /> * MindLight ~ Children's Autism Detection System<br /> * Vibraint ~ Learning Assessment Systems<br /> * BrainState ~ Image-Guided Stroke Rehabilitation<br /> * Data Driven Diagnostics (D3) ~ MRI Tests for Depression<br /> * StrokeDx ~ Stroke Diagnostic Imaging Systems<br /> * iSight ~ Vision Recuperation Solutions<br /> * Sight Beyond Sight ~ Retinal Implant Vision Systems<br /> * PsychCSR ~ Voice-Pattern Call Center QC Systems<br /></blockquote>Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-60378850840168269502008-11-03T06:16:00.000-08:002008-11-03T06:16:44.798-08:00McGovern Institute funds collaborative neurotechnology projects - MIT News Office<a href="http://web.mit.edu/newsoffice/2008/mcgovern-grants-1028.html">McGovern Institute funds collaborative neurotechnology projects - MIT News Office</a><br /><br />The McGovern Institute for Brain Research has announced six new funding awards to develop technologies aimed at accelerating neuroscience research and developing new therapeutic approaches for brain disorders. The new projects are on themes ranging from brain-machine interfaces to new genetic tools and brain imaging methods.<br /><br />The awards are part of the McGovern Institute Neurotechnology (MINT) program, established in 2006 to promote collaborations between neuroscientists and researchers from other disciplines within and beyond MIT. "Neuroscience has always been driven by new technologies," explained Charles Jennings, the MINT program director. "We want to take advantage of the extraordinary range of technological expertise at MIT to develop new methods that could transform the field."<br /><br />The MINT awards typically provide up to $100,000 for one year of seed funding to test innovative ideas that traditional funding sources rarely support, and to determine if they are worth pursuing further.Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-56772984941503073422008-10-11T11:13:00.000-07:002008-10-11T11:13:12.393-07:00November 12, 2008 event<a href="http://www.mitforumcambridge.org/nov.html">November 12, 2008 Innovation Series</a><br /><br />Neuroscience Drug Discovery and Development:<br /><br />The Route to Disease-Modifying Therapies<br /><br />Program Description:<br /><br />Disorders of the brain, including neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease and psychiatric diseases such as schizophrenia and depression, pose some of the hardest challenges for the biopharmaceutical industry. The disease burden from brain disorders is enormous, and the commercial potential is correspondingly attractive to industry and its investors. However, complex pathophysiology, poor preclinical models, a lack of reliable biomarkers and expensive clinical trials all impede development of new therapies. Join us for a discussion of how the biopharmaceutical industry is addressing these challenges, with guest speakers from the cutting edge of neuroscience drug discovery.Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-79262754460223334242008-07-14T19:02:00.000-07:002008-07-14T19:02:22.632-07:00Neurotechnology @ MIT & Beyond - An Enormous Emerging Research & Venture Domain<a href="http://maximizingprogress.blogspot.com/2008/07/neurotechnology-mit-beyond-enormous.html">Neurotechnology @ MIT and Beyond ~ An Enormous Emerging Research and Venture Domain</a>: <br /><br />Joost Bonsen and I are co-organizing another Neurotech@MIT gathering this Tuesday night July 15th 2008, from 7-9pm. This informal evening of drinks, brainstorming, and conversation with fellow inventive and entrepreneurial friends will be at the Royal East over dinner. The Royal East Restaurant is at 792 Main St. Cambridge, MA. We each chip in to split the cost. <br /><br />This Fall 2008, together with Ed Boyden and Rutledge Ellis-Behnke, Joost is co-teaching <a href="http://neuro.media.mit.edu/classes/neuroven/08.fa/">Neurotechnology Ventures, an Institute-wide elective projects-course at MIT</a> on the challenges of envisioning, planning, and building startups to bring neuroengineering innovations to the world..."Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-40346030321568013772008-05-30T05:52:00.000-07:002008-05-30T05:54:02.090-07:00Upcoming Event - June 4thFrom Paul Pyzowski:<br /><br />The Massachusetts Medical Device Group is having a forum on the future of neuroscience and neurotech next Wednesday (June 4) in Waltham. I am moderating a panel that includes Charles Jennings from the McGovern as well as a practicing neurosurgeon and a neurotech entrepreneur.<br /><br />Event link is here:<br /><a href="http://web.memberclicks.com/mc/community/eventdetails.do?eventId=131733&orgId=meg">http://web.memberclicks.com/mc/community/eventdetails.do?eventId=131733&orgId=meg</a><br /><br />MDG link is here:<br /><a href="http://www.meddevgroup.org/">http://www.meddevgroup.org/</a>Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-52289806062326048442008-03-27T21:09:00.000-07:002008-03-28T12:46:53.418-07:00Neurotech Industry Conference<a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_tdB2j9LIjgU/R-xxSPg2XTI/AAAAAAAAAFg/X33P8F1pBko/s1600-h/97.jpg"><img style="display:block; margin:0px auto 10px; text-align:center;cursor:pointer; cursor:hand;" src="http://1.bp.blogspot.com/_tdB2j9LIjgU/R-xxSPg2XTI/AAAAAAAAAFg/X33P8F1pBko/s400/97.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5182641829412494642" /></a><br />Hi all, I really, really recommend that you attend this conference. It's a great opportunity. <br /><br />I have a code for a special $100 discount for MIT Neurotech Club members if you send me an email (eesley at mit).<br /><br /><http://rs6.net/tn.jsp?e=001hNxWI0vL1jzKFlDCYqtL_wy7ZNuJv9fOUozLlhSRYoKcKtBEXHQ9eJzxfRNZMcN0KFhYIMk2VU7JXgYFH0W6xavCVZ2udfCt8D2V79kVDpymAJC9yy0s7H1WcneapbDIapgXieCeB-PZCl2P43BvK9HOWCJ4iVhQ><br /><a href="http://rs6.net/tn.jsp?e=001hNxWI0vL1jzKFlDCYqtL_wy7ZNuJv9fOUozLlhSRYoKcKtBEXHQ9eJzxfRNZMcN0KFhYIMk2VU7JXgYFH0W6xavCVZ2udfCt8D2V79kVDpymAJC9yy0s7H1WcneapbDIapgXieCeB-PZCl2P43BvK9HOWCJ4iVhQ">Register Today</a> <a href="http://rs6.net/tn.jsp?e=001hNxWI0vL1jyNzWI80R_ZGoNi9SV7gAE31lMFvKrN33TcXiJkQmBATHqZx_KE2JRluC3ibwx7cBWdo_hwH_LrLziZ8mVVYOJh0-Qz0FlicY_Bv5F8Qlw91Fs1BwAiyP_m6ryfGE67x6RXH8DgHZYf4TYKvgBuaY7XuU1yFJhy6Cc="> View Agenda</a> <a href="http://rs6.net/tn.jsp?e=001hNxWI0vL1jxFIUaS7mPPZCnI_t6I56B0BBXxhZOSwjvZcFjWRPKQAhkpDLmfuxmTOeKPz_KZwEmILZ3E50IyhFF-E74qwpaC6KMUJfppg8BUow1lp351aT6NYc-1K3oNHEZMZ3WZeLOXI38gvXxYQGQl0uDlhgR0">More Information</a> <br /> Join hundreds of executives, investors, and other leaders from across the neurotech industry at the only partnering and investing conference including drugs, devices and diagnostics for the brain and nervous system.<br /><br />The <a href="http://rs6.net/tn.jsp?e=001hNxWI0vL1jxFIUaS7mPPZCnI_t6I56B0BBXxhZOSwjvZcFjWRPKQAhkpDLmfuxmTOeKPz_KZwEmILZ3E50IyhFF-E74qwpaC6KMUJfppg8BUow1lp351aT6NYc-1K3oNHEZMZ3WZeLOXI38gvXxYQGQl0uDlhgR0">Neurotech Industry Investing and Partnering Conference</a> will take place on May 8-9 at the Westin Copley Place in Boston.<br /><br />Hear about next generation treatments for Alzheimer's, addiction, anxiety, depression, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, traumatic brain injury, spinal cord injury, Parkinson's and other brain-related illnesses.<br /><br />Hear from over 50 neurotech executives and investors in these sessions <br /> - Investing in Neurotech<br />- Addiction, Impluse Control and Obesity<br />- Drug Delivery and the Blood Brain Barrier<br />- Alzheimer's and Cognitive Disorders<br />- Paving the Way in New Markets<br />- Insomnia and Sleep Disorders<br />- Traumatic Brain and Spinal Cord Injury<br />- Partnering and Licensing in Neurotech<br />- Next Generation Neuropsychiatry<br />- Effective Global Clinical Trial Design<br />- Pain: Acute, Chronic and Neuropathic<br />- Neurotech Public Policy 2008<br /><br />Presenting companies include<br /><br />Robert Alonso, President and CEO, Yaupon Therapeutics<br />Gary Ascani, President and CEO, Banyan Biomarkers<br />Kees Been, President and CEO, EnVivo Therapeutics<br />Kerrie Brady, President and CEO, Traxion Therapeutics<br />Kenneth Chahine, President and CEO, Avigen<br />Chris Chavez, President and CEO, Advanced Neuromodulation Systems* <br />Donald deBethizy, President and CEO, Targacept<br />Christopher deCharms, President and CEO, Omneuron<br />Christine de los Reyes, Managing Director, Biotech Partnering Solutions <br />Philip Devlin, EVP and General Manager, Aspect Neuroscience <br />Frank Eeckman, Director, NeuroInsights, Centient Biotech Investor<br />Pieter Gaillard, President and CEO, toBBB<br />Paul Gilbert, CEO, Medavante<br />David Hale, Executive Chairman, Somaxon<br />Michael Kauffman, President and CEO, Epix Pharmaceuticals<br />Jonathan Kil, President and CEO, Sound Pharmaceuticals<br />Mark Knudson, President and CEO, Enteromedics<br />Elliot Krames, President, International Neuromodulation Society<br />Lothar Krinke, VP Business Development, Medtronic Neurological <br />Manuel Lopez-Figueroa, Investment Professional, Bay City Capital<br />Andres Lozano, President and CEO, Functional Neuroscience, Inc.<br />Casey Crawford Lynch, Managing Director, NeuroInsights<br />Zack Lynch, Executive Director, Neurotechnology Industry Organization<br />Sharon Mates, Chairman and CEO, Intra-Cellular Therapies<br />Cris McReynolds, President & CEO, Satoris<br />Erich Mohr, President & CEO, Med-Genesis<br />Dan Moore, President and CEO, Cyberonics<br />Karoly Nikolich, President and CEO, Amnestix<br />Dan O'Connell, Managing Director, NeuroVentures Capital<br />Suzan Onel, Partner, K&L Gates, NIO FDA Policy Counsel <br />Vincent Owens, President and CEO, Intelect Medical <br />Art Pappas, Managing Partner, Pappas Ventures<br />Mark Pykett, President and COO, Alseres Pharmaceuticals <br />Roger Quy, General Partner, Technology Partners<br />Srinivas Rao, Chief Scientific Officer, Cypress Bioscience <br />Wendye Robbins, President and CEO, Limerick Neuroscience<br />Daniel Ritter, Partner, K&L Gates, NIO Public Policy Counsel<br />Luca Santarelli, Global Head, Clinical Research, CNS, Hoffmann-La Roche<br />Jim Schoeneck, President and CEO, BrainCells, Inc.<br />David Schultz, Senior Director, Worldwide Business Development, Pfizer<br />Rajeev Shah, Senior Analyst, RA Capital<br />Uzi Sofer, CEO, Brainsway<br />Tim Surgenor, President and CEO, Cyberkinetics Neurotechnology Systems<br />Tim Tasker, Executive Vice President Clinical Development, Evotec <br />Gary Tollefson, President and CEO, Orexigen <br />Lars Wahlberg, Executive Vice President and COO, NsGene<br />*indicates invited and in process of confirming<br /><br /><br />This market defining conference features keynotes on the state of the industry, cutting edge company presentations, and panel discussions on a comprehensive selection of commercial neuroscience topics.<br /><br /><a href="http://rs6.net/tn.jsp?e=001hNxWI0vL1jzKFlDCYqtL_wy7ZNuJv9fOUozLlhSRYoKcKtBEXHQ9eJzxfRNZMcN0KFhYIMk2VU7JXgYFH0W6xavCVZ2udfCt8D2V79kVDpymAJC9yy0s7H1WcneapbDIapgXieCeB-PZCl2P43BvK9HOWCJ4iVhQ">Click here to register today at early rates</a> <br /><br /><a href="http://origin.ih.constantcontact.com/fs037/1101330298625/img/101.png?a=1102030507697">Gold Sponsors</a><br /><a href="http://rs6.net/tn.jsp?e=001hNxWI0vL1jzMEe0Tw8XFjcbzSdhTmJrCseUUTdJ0HO2mmPdww7ilRk6_cn_k2zZN2hRojz2gjAIdQgrc9ac2GjGXBaWro0Bw1IxpQb3IvEJMJ171282uwnoimIR_XriOuCW3Dih-2-Lsy0v8xpGrBkxQH8J6sn9huFUZBX-SE8Y=">sponsors </a><br /> MIBR <http://origin.ih.constantcontact.com/fs037/1101330298625/img/107.jpg?a=1102030507697><br /><br />Conference Organized by: <a href="http://rs6.net/tn.jsp?e=001hNxWI0vL1jzlhUcOcYpEHE0V9fFHpwVTZ6jCTXeZQBdHo17KhDYJVgQP5XnMIZLvYFmf6JqLP689H43GbQ-Iuf-vb4hnrq1uTOUgeILXYlDJ7x4HZVGnr3juw1l5KL3c4DC1E1ggHFo=">NeuroInsights</a>Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-89150998617500599102008-02-22T08:02:00.001-08:002008-02-22T08:02:55.017-08:00NeuroTech Conference<a href="http://www.neuroinsights.com/events/neurotech2008.html">http://www.neuroinsights.com/events/neurotech2008.html</a>Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-81383184272753774772008-02-17T17:09:00.000-08:002008-02-17T17:09:47.975-08:00MIT Grad Kurzweil on Neurotech Future<a href="http://news.bbc.co.uk/2/hi/americas/7248875.stm">BBC NEWS | Americas | Machines to match man by 2029'</a><br /><br /><a href=""></a><br /><blockquote>Humans and machines would eventually merge, by means of devices embedded in people's bodies to keep them healthy and improve their intelligence, predicted Mr Kurzweil.<br /><br />"We'll have intelligent nanobots go into our brains through the capillaries and interact directly with our biological neurons," he told BBC News.<br /><br />CHALLENGES FACING HUMANITY<br />Make solar energy affordable<br />Provide energy from fusion<br />Develop carbon sequestration<br />Manage the nitrogen cycle<br />Provide access to clean water<br />Reverse engineer the brain<br />Prevent nuclear terror<br />Secure cyberspace<br />Enhance virtual reality<br />Improve urban infrastructure<br />Advance health informatics<br />Engineer better medicines<br />Advance personalised learning<br />Explore natural frontiers<br /><br />The nanobots, he said, would "make us smarter, remember things better and automatically go into full emergent virtual reality environments through the nervous system".<br /><br />Mr Kurzweil is one of 18 influential thinkers chosen to identify the great technological challenges facing humanity in the 21st century by the US National Academy of Engineering.<br /><br />The experts include Google founder Larry Page and genome pioneer Dr Craig Venter.<br /><br />The 14 challenges were announced at the annual meeting of the American Association for the Advancement of Science in Boston, which concludes on Monday. <br /></blockquote>Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-51418694224238927422008-02-11T13:51:00.001-08:002008-02-11T13:51:23.045-08:00Minds @ the MuddyHi all,<br /><br />Joost Bonsen, Christian Wentz, Jon Edward and I are hosting an informal gathering of those interested in all things neurotech Tues. Feb. 19th from 8pm-onward. Details below.<br /><br />I hope you'll drop by!<br /><br />If you would like to help organize this, please email me at eesley@mit.edu<br /><br />Chuck<br /><br />"Minds at the Muddy" will kick off Feb. 19th at 8pm at the Muddy Charles Pub at MIT. We're bringing together the hottest minds and up and coming entrepreneurs in the Neurotechnology area for an exciting evening of drinks, brainstorming, and conversation.<br /><br />Please join fellow inventive and entrepreneurial friends and me at the MIT<br />Muddy Charles pub Feb. 19th (Tues.), between 8pm and<br />10pm, for drinks, dinner, and interesting discussions. This informal<br />"Minds at the Muddy" will go till at least 9:30p, probably later.<br /><br />We're personally inviting people who we know like to work on new technologies,<br />entrepreneurial ventures, or other efforts which maximize human progress.<br /><br />Legalities -- Please don't forget your ID since unconstitutional age<br />discrimination remains in force.<br /><br />Locale -- Free parking and the Kendall T are a short walk from the Muddy --<br />http://web.mit.edu/muddy/ -- which is in the corner of MIT building 50, the<br />big, pillared Walker Memorial near the intersection of Ames St and Memorial<br />Drive -- http://whereis.mit.edu/bin/map?mapterms=muddy&mapsearch=go<br /><br />Cost -- Typically people chip in by purchasing<br />a pitcher or so and contributing it to the gathering.<br /><br />PS If there's someone you think I ought to invite to this, please drop me a line! eesley@mit.eduAnonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0tag:blogger.com,1999:blog-3545971560190127785.post-16206767937069660252007-12-09T13:14:00.000-08:002007-12-09T13:20:39.665-08:00Introducing the Neurotech ClubBorn out of the "Brain Futures" event, part of Flagship Ventures Explorations series, we are initiating a student organization focusing on neurotechnology. Much of the text below comes from the previous iteration of this club at MIT which was organized by Joost Bonsen. The vision below should be credited to his efforts. This group and the blog is open to new contributors. Feel free to contact Chuck Eesley for more information and to subscribe to the neurotech email list hosted at MIT.<br /><br />The NeuroTech Club is a new MIT/Harvard/BU-wide student organization which aims to (a) advance understanding of emerging applied neuroscience & neuroengineering advances, (b) to serve researchers from throughout MIT through events and activities, and (c) to build links between interested science, engineering, and business communities at and beyond the Institute.<br /><br />Neurotechnologies are a broad emerging area of research activity at MIT, and correspondingly, a major arena for discovery, innovation, & entrepreneurship.<br /> <br />MIT Neuro Efforts Generally<br /><br />Many labs & departments at MIT are pursuing different aspects & approaches to Neurotechnology. In the School of Science, Biology and Brain & Cognitive Science each have faculty seeking fundamental understanding of neural development & brain function. In the School of Engineering, Mechanical Engineers, Materials Scientists, Electrical Engineers, Chemical Engineers, Biological Engineers, and more, investigate neuromorphic computing, artificial intelligence, prostheses, motor-control systems, and neuroengineering generally ( http://hst.mit.edu/nerc/ ). MIT Labs actively involved in this domain include MTL, RLE, HST, AI, CBCL, BCS, McGovern, Whitehead, Picower, Martinos, and more.Anonymoushttp://www.blogger.com/profile/16409965988150068402noreply@blogger.com0